Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2013 1
2017 2
2018 8
2019 9
2020 13
2021 5
2022 10
2023 22
2024 19
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, Sambataro G, Bauer-Ventura I, Bae SS, Lim D, Rivero-Gallegos D, Yamano Y, Selva-O'Callaghan A, Mammen AL, Scirè CA, Montecucco C, Oddis CV, Fiorentino D, Bonella F, Miller FW, Lundberg IE, Schmidt J, Rojas-Serrano J, Hudson M, Kuwana M, González-Gay MA, McHugh N, Corte TJ, Doyle TJ, Werth VP, Gupta L, Perez Roman DI, Bianchessi LM, Devarasetti PK, Shinjo SK, Luppi F, Cavazzana I, Moghadam-Kia S, Fornaro M, Volkmann ER, Piga M, Loarce-Martos J, De Luca G, Knitza J, Wolff-Cecchi V, Sebastiani M, Schiffenbauer A, Rider LG, Campanilho-Marques R, Marts L, Bravi E, Gunawardena H, Aggarwal R, Cavagna L; Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators. Faghihi-Kashani S, et al. Arthritis Rheumatol. 2025 Apr;77(4):477-489. doi: 10.1002/art.43038. Epub 2024 Dec 17. Arthritis Rheumatol. 2025. PMID: 39467037 Free PMC article.
Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.
Demortier J, Vautier M, Chosidow O, Gallay L, Bessis D, Berezne A, Cordel N, Schmidt J, Smail A, Duffau P, Jachiet M, Begon E, Gottlieb J, Chasset F, Graveleau J, Marque M, Cesbron E, Forestier A, Josse S, Kluger N, Beauchêne C, Le Corre Y, Pagis V, Rigolet A, Guillaume-Jugnot P, Authier FJ, Guilain N, Streichenberger N, Leonard-Louis S, Boussouar S, Landon-Cardinal O, Benveniste O, Allenbach Y. Demortier J, et al. Among authors: landon cardinal o. Rheumatology (Oxford). 2023 Dec 1;62(12):3932-3939. doi: 10.1093/rheumatology/kead154. Rheumatology (Oxford). 2023. PMID: 37010495 Review.
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
Dey M, Doskaliuk B, Parodis I, Lindblom J, Wincup C, Joshi M, Dey D, Katchamart W, Kadam E, Sen P, Shinjo SK, Nune A, Goo PA, Ziade N, Chen YM, Traboco LS, Gutiérrez CET, Vaidya B, Agarwal V, Gupta L, Nikiphorou E; COVAD Study Group. Dey M, et al. Rheumatol Int. 2024 Dec;44(12):2853-2861. doi: 10.1007/s00296-024-05742-x. Epub 2024 Nov 6. Rheumatol Int. 2024. PMID: 39503760 Free PMC article.
Anti-synthetase syndrome occurring after SARS-CoV-2 infection.
Bouchard Marmen M, Ellezam B, Fritzler MJ, Troyanov Y, Gould PV, Satoh M, Meyer A, Mahjoub Z, Landon-Cardinal O. Bouchard Marmen M, et al. Among authors: landon cardinal o. Scand J Rheumatol. 2022 May;51(3):255-257. doi: 10.1080/03009742.2021.2024019. Epub 2022 Feb 9. Scand J Rheumatol. 2022. PMID: 35138215 No abstract available.
The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis.
Bishnoi A, Tang IYK, Yoshida A, Pais FM, Usman SY, Dominguez SA, Kavadichanda CG, Rivero-Gallegos D, Dourado E, Conticini E, Bozán F, Tulluru G, Lilleker JB, Sreerama Reddy K, Landon-Cardinal O, Smaili R, Keret S, Khoo T, Lan TY, Leclair V, Oddis CV, Vencovský J, Kuwana M, Gandiga PC, Aggarwal R; Myositis Clinical Trials Consortium investigators. Bishnoi A, et al. Among authors: landon cardinal o. Clin Exp Rheumatol. 2025 Feb;43(2):202-210. doi: 10.55563/clinexprheumatol/k7665a. Epub 2025 Feb 20. Clin Exp Rheumatol. 2025. PMID: 39977016 Free article.
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D, Cavagna L, Makol A, Gutiérrez CET, Caballero Uribe CV, Kuwana M, Burmester GR, Ziade N, Wincup C, Andreoli L, Parodis I, Tan AL, Guillemin F, Knitza J, Wang G, Dalbeth N, Velikova T, Gracia-Ramos AE, Nikiphorou E, Day J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD study group. Joshi M, et al. Int J Rheum Dis. 2024 May;27(5):e15161. doi: 10.1111/1756-185X.15161. Int J Rheum Dis. 2024. PMID: 38720408
Expanding the spectrum of HIV-associated myopathy.
Landon-Cardinal O, Gallay L, Dubourg O, Maisonobe T, Léonard-Louis S, Beniken D, Simon A, Behin A, Stojkovic T, Duyckaerts C, Breton G, Rigolet A, Fain O, Meyohas MC, Leport C, Valantin MA, Vittecoq D, Bergmann JF, Hanslik T, Chauveheid MP, Amoura Z, de Broucker T, Eymard B, Beaudequin N, Benveniste O, Allenbach Y. Landon-Cardinal O, et al. J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1296-1298. doi: 10.1136/jnnp-2018-319419. Epub 2019 Apr 11. J Neurol Neurosurg Psychiatry. 2019. PMID: 30975823 No abstract available.
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.
Benveniste O, Hogrel JY, Belin L, Annoussamy M, Bachasson D, Rigolet A, Laforet P, Dzangué-Tchoupou G, Salem JE, Nguyen LS, Stojkovic T, Zahr N, Hervier B, Landon-Cardinal O, Behin A, Guilloux E, Reyngoudt H, Amelin D, Uruha A, Mariampillai K, Marty B, Eymard B, Hulot JS, Greenberg SA, Carlier PG, Allenbach Y. Benveniste O, et al. Among authors: landon cardinal o. Lancet Rheumatol. 2021 Jan;3(1):e40-e48. doi: 10.1016/S2665-9913(20)30280-0. Epub 2020 Oct 12. Lancet Rheumatol. 2021. PMID: 38273639
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Kuwana M, Joshi M, Gracia-Ramos AE, Boyd P, Yaadav P, Cheng K, Kobert L, Cavagna L, Sen P, Day J, Makol A, Gutiérrez CET, Caballero-Uribe CV, Saha S, Parodis I, Dey D, Nikiphorou E, Distler O, Kadam E, Tan AL, Shinjo SK, Ziade N, Knitza J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD Study Group. Shumnalieva R, et al. Int J Rheum Dis. 2024 May;27(5):e15178. doi: 10.1111/1756-185X.15178. Int J Rheum Dis. 2024. PMID: 38742751
92 results